These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Investigating the clearance of VWF A-domains using site-directed PEGylation and novel N-linked glycosylation. Fazavana J; Brophy TM; Chion A; Cooke N; Terraube V; Cohen J; Parng C; Pittman D; Cunningham O; Lambert M; O'Donnell JS; O'Sullivan JM J Thromb Haemost; 2020 Jun; 18(6):1278-1290. PubMed ID: 32108991 [TBL] [Abstract][Full Text] [Related]
10. The Biological Significance of von Willebrand Factor O-Linked Glycosylation. Ward S; O'Sullivan JM; O'Donnell JS Semin Thromb Hemost; 2021 Oct; 47(7):855-861. PubMed ID: 34130346 [TBL] [Abstract][Full Text] [Related]
11. Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations. Millar CM; Riddell AF; Brown SA; Starke R; Mackie I; Bowen DJ; Jenkins PV; van Mourik JA Thromb Haemost; 2008 May; 99(5):916-24. PubMed ID: 18449422 [TBL] [Abstract][Full Text] [Related]
12. A novel role for the macrophage galactose-type lectin receptor in mediating von Willebrand factor clearance. Ward SE; O'Sullivan JM; Drakeford C; Aguila S; Jondle CN; Sharma J; Fallon PG; Brophy TM; Preston RJS; Smyth P; Sheils O; Chion A; O'Donnell JS Blood; 2018 Feb; 131(8):911-916. PubMed ID: 29282218 [TBL] [Abstract][Full Text] [Related]
15. Platelet von Willebrand factor--structure, function and biological importance. McGrath RT; McRae E; Smith OP; O'Donnell JS Br J Haematol; 2010 Mar; 148(6):834-43. PubMed ID: 20067560 [TBL] [Abstract][Full Text] [Related]
16. Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis. McGrath RT; van den Biggelaar M; Byrne B; O'Sullivan JM; Rawley O; O'Kennedy R; Voorberg J; Preston RJ; O'Donnell JS Blood; 2013 Dec; 122(25):4107-10. PubMed ID: 24106205 [TBL] [Abstract][Full Text] [Related]
17. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor. Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141 [TBL] [Abstract][Full Text] [Related]
18. The plasma von Willebrand factor O-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs. Canis K; McKinnon TA; Nowak A; Panico M; Morris HR; Laffan M; Dell A J Thromb Haemost; 2010 Jan; 8(1):137-45. PubMed ID: 19874459 [TBL] [Abstract][Full Text] [Related]